Otolaryngological symptoms associated with positive RT-PCR SARS-CoV-2 infection: a case-control study in Colombia

Main Article Content

Lucia C. Pérez-Herrera
Sergio Moreno-López
Irene C. Pérez-García
Carolina Hernández
Gloria Corredor-Rojas
Javier Ospina
Juan P. Vargas Gallo
Daniel Peñaranda
Augusto Peñaranda

Abstract

Introduction: Otolaryngological disorders in COVID-19 patients have drawn attention worldwide. However, there is still no consensus regarding the prevalence,
severity or recovery of these disorders. This study aimed to assess the association
between otolaryngological symptoms and SARS-CoV-2 positivity confirmed by
RT-PCR, as well as the severity, duration, and recovery of these


Introduction: Otolaryngological disorders in COVID-19 patients have drawn at[1]tention worldwide. However, there is still no consensus regarding the prevalence, severity or recovery of these disorders. This study aimed to assess the association between otolaryngological symptoms and SARS-CoV-2 positivity confirmed by RT-PCR, as well as the severity, duration, and recovery of these symptoms in pa[1]tients receiving care at Fundación Santa Fe de Bogotá, a COVID-19 referral hospital in Bogotá, Colombia. Methods: Observational, analytic, prospective, case-control study conducted between October 9, 2020, and January 14, 2021. Cases included adults who tested positive for SARS-CoV-2 by reverse transcription-polymerase chain reaction (RT-PCR). Cases were matched in a 2:1 ratio with randomly selected symptomatic adults with a negative test, or patients awaiting surgery. Results: Of 10004 patients tested for SARS-CoV-2, 130 cases and 253 controls were included. The mean age was 41.8 years (standard deviation [SD]: 16.3). The otolaryngological symptoms associated with SARS-CoV-2 positivity were anosmia/hyposmia (adjus[1]ted odds ratio [aOR]: 5.82; 95% confidence interval [CI]: 1.92-17.68), dysgeusia/ hypogeusia (aOR: 9.09; 95% CI: 2.86-28.92), and dry cough (aOR: 3.18; 95% CI: 1.56-6.48). The median duration of anosmia/hyposmia and dysgeusia/hypogeusia in SARS-CoV-2 positive patients was 14.5 

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Pérez-Herrera LC, Moreno-López S, Pérez-García IC, Hernández C, Corredor-Rojas G, Ospina J, Vargas Gallo JP, Peñaranda D, Peñaranda A. Otolaryngological symptoms associated with positive RT-PCR SARS-CoV-2 infection: a case-control study in Colombia. Acta otorrinolaringol cir cabeza cuello [Internet]. 2022Dec.30 [cited 2024May11];50(4):262 - 272. Available from: https://www.revista.acorl.org.co/index.php/acorl/article/view/654
Section
Trabajos Originales

References

Mayo-Yáñez M, Palacios-García JM, Calvo-Henríquez C, Ayad T, Saydy N, León X, et al. COVID-19 Pandemic and its Impact on the Management of Head and Neck Cancer in the Spanish Healthcare System. Int Arch Otorhinolaryngol. 2021;25(4):e610–5. 10.1055/s-0041-1736425

Demombynes G. COVID-19 Age-Mortality Curves are Flatter in Developing Countries. Washington DC: World Bank; 2020. p. 1-31. doi: 10.1596/1813-9450-9313

Brandão Neto D, Pinna F de R. COVID-19 and Anosmia: Remaining Gaps to Knowledge. Int Arch Otorhinolaryngol. 2021;25(4):e479-80. doi: 10.1055/s-0041-1736563

Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, et al. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping

Review and Meta-Analysis. J Clin Med. 2020;9(4):941. doi: 10.3390/jcm9040941

Miyake MM, Anselmo-Lima WT. Monitoring of cases of anosmia may help control the COVID-19 pandemic. Braz J Otorhinolaryngol. 2021;87(4):377-78. doi: 10.1016/j. bjorl.2021.02.001

Lechien JR, Chiesa-Estomba CM, Vaira LA, De Riu G, Cammaroto G, Chekkoury-Idrissi Y, et al. Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021;278(8):2851-859. doi: 10.1007/s00405-020-06548-w

Ozçelik Korkmaz M, Egilmez OK, Ozçelik MA, Guven M. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. Eur Arch Otorhinolaryngol.

;278(5):1675-685. doi: 10.1007/s00405-020-06396-8

Kapoor S, Gupta A, Saidha PK. Ear, Nose, and Throat Practice Guidelines: An Update for COVID-19. Int Arch Otorhinolaryngol. 2021;25(4):e621-e627. doi: 10.1055/s-0041-1736424

Carrillo-Larco RM, Altez-Fernandez C. Anosmia and dysgeusia in COVID-19: A systematic review. Wellcome Open Res. 2020;5:94. doi: 10.12688/wellcomeopenres.15917.1

Machin D, Campbell M, Tan S, Tan S-H. Comparing Two Independent Groups for Binary Data. In: Sample Size Tables for Clinical Studies. Oxford, UK: Wiley-Blackwell; 2011. p. 30-41. doi: 10.1002/9781444300710.ch3

Whitcroft KL, Hummel T. Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA. 2020;323(24):2512-514. doi: 10.1001/jama.2020.8391

Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate

coronavirus disease 2019. J Intern Med. 2020;288(3):335-44. doi: 10.1111/joim.13089

Dicpinigaitis PV, Canning BJ. Is There (Will There Be) a PostCOVID-19 Chronic Cough? Lung. 2020;198(6):863-65. doi: 10.1007/s00408-020-00406-6

Saniasiaya J, Islam MA, Abdullah B. Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Metaanalysis of 27,492 Patients. Laryngoscope. 2021;131(4):865-

doi: 10.1002/lary.29286

Bagheri SHR, Asghari AM, Farhadi M, Shamshiri AR, Kabir A, Kamrava SK, et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak. medRxiv. 2020;2020.03.23.20041889. doi: 10.1101/2020.03.23.20041889

Lee Y, Min P, Lee S, Kim SW. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients. J KoreaMed Sci. 2020;35(18):e174. doi: 10.3346/jkms.2020.35.e174

Patel ZM. Olfactory Loss and Olfactory Training. JAMA Otolaryngol Head Neck Surg. 2021;147(9):840. doi: 10.1001/jamaoto.2021.1507

Gengler I, Wang JC, Speth MM, Sedaghat AR. Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: A systematic review of the current evidence. Laryngoscope Investig

Otolaryngol. 2020;5(3):354-59. doi: 10.1002/lio2.384

Speth MM, Singer-Cornelius T, Oberle M, Gengler I, Brockmeier SJ, Sedaghat AR. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing,

and Associated Characteristics. Otolaryngol Head Neck Surg. 2020;163(1):114-20. doi: 10.1177/0194599820929185

Naeini AS, Karimi-Galougahi M, Raad N, Ghorbani J, Taraghi A, Haseli S, et al. Paranasal sinuses computed tomography findings in anosmia of COVID-19. Am J Otolaryngol.

;41(6):102636. doi: 10.1016/j.amjoto.2020.102636

Naunheim MR, Zhou AS, Puka E, Franco RA Jr, Carroll TL, Teng SEet al. Laryngeal complications of COVID-19. Laryngoscope Investig Otolaryngol. 2020;5(6):1117-124. doi:

1002/lio2.484

Maharaj S, Bello Alvarez M, Mungul S, Hari K. Otologic dysfunction in patients with COVID-19: A systematic review. Laryngoscope Investig Otolaryngol. 2020;5(6):1192-196. doi:

1002/lio2.498

Almufarrij I, Uus K, Munro KJ. Does coronavirus affect the audio-vestibular system? A rapid systematic review. Int J Audiol. 2020;59(7):487-91. doi: 10.1080/14992027.2020.1776406

Sriwijitalai W, Wiwanitkit V. Hearing loss and COVID-19: A note. Am J Otolaryngol. 2020;41(3):102473. doi: 10.1016/j.amjoto.2020.102473

Kilic O, Kalcioglu MT, Cag Y, Tuysuz O, Pektas E, Caskurlu H, et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARSCOV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 2020;97:208-11. doi: 10.1016/j.ijid.2020.06.023

Fidan V. New type of corona virus induced acute otitis media in adult. Am J Otolaryngol. 2020;41(3):102487. doi: 10.1016/j.amjoto.2020.102487

Karimi-Galougahi M, Naeini AS, Raad N, Mikaniki N, Ghorbani J. Vertigo and hearing loss during the COVID-19 pandemic - is there an association? Acta Otorhinolaryngol Ital.

;40(6):463-65. doi: 10.14639/0392-100X-N0820

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-06. doi: 10.1016/

S0140-6736(20)30183-5

House T, Keeling MJ. Household structure and infectious disease transmission. Epidemiol Infect. 2009;137(5):654-61. doi: 10.1017/S0950268808001416

Phucharoen C, Sangkaew N, Stosic K. The characteristics of COVID-19 transmission from case to high-risk contact, a statistical analysis from contact tracing data. EClinicalMedicine.

;27:100543. doi: 10.1016/j.eclinm.2020.100543

Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32(1-2):51-63. doi: 10.1016/0021-9681(79)90012-2

Manterola C, Otzen T. Bias in Clinical Research. Int J Morphol. 2015;33(3):1156-64. doi: 10.4067/S0717-95022015000300056

Böger B, Fachi MM, Vilhena RO, Cobre AF, Tonin FS, Pontarolo R. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. Am J Infect Control. 2021;49(1):21-29. doi: 10.1016/j.ajic.2020.07.011

Most read articles by the same author(s)